Subsequent experiments demonstrated that BBR targets JAK1 protein, inhibiting the IL-4-JAK1-STAT6 axis to suppress M2 polarization of tumor-infiltrating macrophages, thereby enhancing tumor suppression. Here, IL4 is linked to neoplasm.